Chloramphenicol antibody causing interference in antibody detection and identification tests

Investigation of the serum of three patients with positive antibody detection tests demonstrated the cause in each to be an antibody against chloramphenicol, a bacteriostatic agent used in commercial red blood cell reagents. Washing of these red cells prior to use prevented agglutination. All three examples of anti-chloramphenicol antibody were IgM and were in low titer when tested at room temperature and 37 C in saline. Two of the antibodies bound complement. The possibility of an antibody to an ingredient of the commercial preservative solution should be considered if problems are encountered in tests with unwashed commercial red blood cell reagents.     

Preparation and storage of platelet concentrates. I. Factors influencing the harvest of viable platelets from whole blood

Abnormalities of the systemic atrioventricular (A-V) valve are frequently present in patients with corrected transposition. Systemic A-V valve regurgitation is usually present and may be amenable to operative correction with valve replacement if the regurgitation is caused by normally positioned but deformed valve leaflets or a dilated valve ring, or both. Systemic A-V valve regurgitation secondary to the more common Ebstein-type malformation of the inverted tricuspid valve is an inoperable conditon at present. Displacement of the valve leaflets below the level of the valve ring may be seen in the angiocardiograms of patients with this finding and is the differentiating feature between the two lesions. Ten cases of systemic A-V valve regurgitation in patients with corrected transposition are reviewed to illustrate these features.     

A comparative diuretic and tissue distribution study of bumetanide and furosemide in the dog

Intravenous dose-response data obtained from renal clearance studies in anesthetized dogs indicated that bumetanide was approximately 30-fold more potent than furosemide in enhancing sodium excretion. After the administration of 0.01 mg/kg of bumetanide or 1.0 mg/kg of furosemide, the relationship between i.v. diuretic activity and tissue distribution was evaluated. In dog renal clearance experiments, bumetanide and furosemide significantly enhanced urine flow, sodium and potassium excretion. Inulin clearance as an estimate of glomerular filtration rate was not altered by either drug, but sodium reabsorption was decreased with bumetanide (13%) and furosemide (12%). At these diuretic doses, both compounds were bound to dog plasma protein to about the same extent (86-91%), although total plasma levels were 100-fold higher for furosemide. Within 1/2 hour after the i.v. administration of 14C-bumetanide or 14C-furosemide, 86 to 99% of the 14C in urine, plasma, kidney, and liver appeared as unchanged drug. One minute after maximal diuresis bumetanide was found to have a higher affinity (3-fold) for kidney compared to furosemide. These data offer a possible explanation for the i.v. diuretic potency difference between these two compounds. Furthermore, the lack of significant difference in plasma protein binding and the absence of urinary metabolites of either drug suggest that other factors may also contribute to the marked differences in diuretic activity between bumetanide and furosemide.     

Extreme catalysts from low-temperature environments

Cold-loving or psychrophilic organisms are widely distributed in nature as a large part of the earth's surface is at temperatures around 0 degrees C. To maintain metabolic rates and to prosper in cold environments, these extremophilic organisms have developed a vast array of adaptations. One main adaptive strategy developed in order to cope with the reduction of chemical reaction rates induced by low temperatures is the synthesis of cold-adapted or psychrophilic enzymes. These enzymes are characterized by a high catalytic activity at low temperatures associated with a low thermal stability. A study of protein adaptation strategies suggests that the high activity of psychrophilic enzymes could be achieved by the destabilization of the active site, allowing the catalytic center to be more flexible at low temperatures, whereas other protein regions may be destabilized or as rigid as their mesophilic counterparts. Due to these particular properties, psychrophilic enzymes offer a high potential not only for fundamental research but also for biotechnological applications.     

Initial steps of the metal-catalysed degradation of L-dehydroascorbic acid in acidic aqueous solutions

The initial steps of the degradation of L-de- hydroascorbic acid (L-DHA) in acidic aqueous solutions and the catalytic effect of different transition metal ions on this reaction were studied. The main product was identified as 3,6-furanosido-2,3-hexodiulosonic acid-2-hydrate (compound I) by GLC-MS and ¹³C-NMR, formed by lactone hydrolysis and hydration of the carbonyl group in the C-2 position of L-dehydroascorbic acid. In addition, number of other compounds were detected; they are formed from compound I by simple enolisation, lactonisation, hydration and dehydration reactions as well as by cleavage and formation of cyclic half acetal bonds. The chemical structures of these compounds were tentatively deduced by the mass spectra of their TMS derivatives and a reaction scheme for their formation is proposed. The velocity and the direction of the reactions were found to be strongly influenced by the presence of catalytic amounts of different transition metal ions. It was concluded that in acidic medium, in contrast to the situation in neutral and alkaline solutions, the opening of the lactone ring of L-DHA is, to a certain degree, a reversible reaction.     

Effects of hydrolyzed spray dried red blood cells in milk replacer on calf intake, body weight gain, and efficiency

An alternative protein ingredient based on spray-dried, hydrolyzed red blood cells was evaluated in calf milk replacers. Two experiments were conducted to determine the value of the ingredient on intake, growth, and feed efficiency in dairy calves. In experiment 1, Holstein bull calves (n = 120) were fed calf milk replacer containing 0, 11, 22, or 43% of crude protein as spray dried hydrolyzed red blood cells. Calves were fed 454 g/d of experimental milk replacer reconstituted to 12% dry matter plus a conventional calf starter for 28 d. Body weight gain, intake of milk replacer and calf starter, feed efficiency, fecal scores, and days scouring were unaffected by source of protein. In experiment 2, Holstein calves (n = 69) at the University of Minnesota, Crookston and Waseca were fed milk replacer containing 0, 22, or 43% of crude protein as spray dried hydrolyzed red blood cells. Calves were fed 454 g/d of experimental milk replacer reconstituted to 12% dry matter plus a conventional calf starter containing 0 or 25% alfalfa meal for 35 d. No calves died during the study. Body weight gain, feed efficiency, intake of calf starter and milk replacer, fecal scores, and days scouring were unaffected by increasing hydrolyzed red blood cells in milk replacer. Similar performance of all calves indicated that spray dried hydrolyzed red blood cells can replace up to 43% of crude protein from whey protein concentrate without detrimental effects on animal performance.     

Molecular analysis of T-cell receptor repertoire in bone marrow transplant recipients: evidence for oligoclonal T-cell expansion in graft-versus-host disease lesions

We have analyzed the T-cell receptor (TCR) V beta repertoire using polymerase chain reaction (PCR) in a cohort of eight patients receiving allogeneic bone marrow transplantation (BMT) from related and unrelated donors at the City of Hope. Results of PCR studies from graft-versus-host disease (GVHD) skin lesions show a bias in the usage of TCR V beta families, whereas examination of peripheral blood (PB) withdrawn at the same time did not reveal a similar phenomenon. In one such family, TCR V beta 2 is predominantly expressed in 7 of 7 biopsy specimens examined. V beta 2 TCR expression from these patients was analyzed more extensively using a combination of individual TCR gene cloning, followed by sequence analysis. We found evidence of oligoclonal expansion of single V beta 2-bearing TCRs in GVHD lesions, and in the PB of some patients after diagnosis of GVHD. In contrast, GVHD-negative biopsy samples showed no evidence for clonotypic TCR amplification. Sequence-specific TCR CDR3 region probes were derived from analysis of the predominant expressed TCR in GVHD lesions, and used to probe Southern blots of amplified V beta 2 TCR mRNA from PB and tissue from BMT recipients and their respective donors. In most cases the probes are highly specific in detecting TCR expression from GVHD lesions alone, although in several instances expression could be detected in PB after GVHD diagnosis. These data provide supporting evidence for the hypothesis that acute GVHD is associated with expansion of T-cell clones expressing antigen-specific TCRs that may contribute to the disease pathology.